Anteris Technologies Ltd at EuroPCR 2023 Physician Panel Transcript

May 16, 2023 - May 19, 2023 / NTS GMT
Susheel Kodali - Columbia University - Director, Structural Heart & Valve Center

Hello, welcome everyone. My name is Susheel Kodali from Columbia University in New York. It's great to be back in Paris in EuroPCR. We have an exciting discussion today talking about the early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve called DurAVR.

I'm joined by my friends and colleagues, Chris Meduri from Karolinska University in Stockholm, and João Cavalcante from Minneapolis Heart Institute. So welcome, Chris. Joe, welcome.

Chris Meduri - Anteris Technologies Ltd - Chief Medical Officer

Thank you.

João Cavalcante - Minneapolis Heart Institute - Director, Cardiac MRI, Structural CT & Cardiovascular Imaging Core Lab

Thank you, Susheel.

Susheel Kodali - Columbia University - Director, Structural Heart & Valve Center

So we want to start a little bit -- I mean, TAVR over the last 15 years has really evolved

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot